(Sr) DM at Eli Lilly and Company

Nanjing, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

全日制本科学历，临床、药学等相关专业优先
2-3年MNC公司地区经理管理经验优先
具有良好的策略性区域管理能力、业务执行力以及领导力
富有责任心，善于学习、自我激励和策略性
诚实正直、高合规意识、重视人员及团队发展和跨部门协作
过往无违反合规和违纪的行为记录

Responsibilities

负责所辖区域团队管理，以高合规标准负责公司产品在区域内的推广和医药观念传播工作，对最后结果负责
与重点客户、政府相关部门及专家建立并保持良好关系
负责团队人员招募与发展，根据公司制度对直接下属进行管理与考核
负责区域科室会的组织召开，推广活动支持
具有高合规意识，并能通过高合规的业务行为来负责管理所辖区域和产品组的各项业务，制定地区目标、业务策略和发展方向，并完成公司以及大区下达的工作目标
负责区域的人员招聘、团队的发展、员工绩效管理和辅导以及把控团队合规风险
严格遵从国家以及公司的政策，确保团队的合规性、学术性、专业性
确保专业拜访和学术研讨活动的全面实施和及时反馈
与重点学术带头人和专家保持良好沟通，以确保和支持市场活动的高合规性与学术专业性
组织和协调跨部门的合作，完成共同目标

Skills

Team Management

Regional Management

Compliance

Staff Recruitment

Performance Management

Stakeholder Engagement

Strategic Planning

Leadership

Cross-functional Collaboration

Academic Promotion

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free